Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease

Authors

  • Luca Di Lullo U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)
  • Fulvio Floccari U.O.C. Nefrologia e Dialisi, Ospedale San Paolo, Civitavecchia (RM)
  • Rodolfo Rivera Divisione di Nefrologia, Ospedale S. Gerardo, Monza
  • Antonio De Pascalis U.O.C. Nefrologia, Dialisi e Trapianto, Ospedale V. Fazzi, Lecce
  • Vincenzo Barbera U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)
  • Moreno Malaguti U.O.C. Nefrologia e Dialisi, Ospedale San Paolo, Civitavecchia (RM)
  • Alberto Santoboni U.O.C. Nefrologia e Dialisi, Ospedale L. Parodi-Delfino, Colleferro (RM)

DOI:

https://doi.org/10.33393/gcnd.2014.921

Keywords:

Cardiovascular disease, Type 4 cardiorenal syndrome, Left ventricular hypertrophy, Echocardiography

Abstract

Cardiovascular diseases such as coronary artery disease, congestive heart failure, arrhythmias, and sudden cardiac death represent main causes of morbidity and mortality in patients with chronic kidney disease (CKD). Their pathogenesis relates to the close linkage between heart and kidneys and involves both traditional and non-traditional risk factors. According to the well-established classification of cardio-renal syndrome, the cardiovascular involvement in chronic kidney disease is known as “type 4 cardiorenal syndrome” (chronic renocardiac syndrome). Uremic cardiopathy is mainly characterized by both left ventricular systolic and diastolic impairment, often associated to right heart dysfunction due to the presence of a vascular access for hemodialysis. The typical clinical picture is represented by left ventricular hypertrophy (LVH), the pathogenesis of which is multifactorial and closely linked to elevated blood pressure, vascular stiffness and atherosclerosis. The diagnosis is mainly made by ultrasound (2D and 3D echocardiography) and cardiac magnetic resonance imaging (CMRI), although echocardiography is most widely employed since it is non-invasive and cheaper than CMRI. The following chapter provides an overview of the epidemiology, pathophysiology, diagnosis, and treatment of left ventricular hypertrophy in CKD patients. (Cardionephrology)

Downloads

Download data is not yet available.

Published

2014-10-09

How to Cite

Di Lullo, L., Floccari, F., Rivera, R., De Pascalis, A., Barbera, V., Malaguti, M., & Santoboni, A. (2014). Left Ventricular Hypertrophy in Patients with Chronic Kidney Disease. Giornale Di Clinica Nefrologica E Dialisi, 26(3), 281–289. https://doi.org/10.33393/gcnd.2014.921

Issue

Section

Cardionephrology

Metrics